Skip to main content

Table 2 Adverse reactions of pirfenidone treatment

From: The effects and safety of pirfenidone in the treatment of idiopathic pulmonary fibrosis: a meta-analysis and systematic review

Study ID

Main adverse reactions

Major adverse reactions leading to interruption of treatment

Azuma 2005

Photosensitivity (43.8%), gastrointestinal discomfort (30.1%), anorexia (31.5%)

Photosensitivity (5 cases), vomiting, fever, abnormal liver function, dizziness, facial paralysis, hepatocellular tumor (1 case each)

CAPACITY 2011

Nausea (36.0%), skin rash (32.0%)

Nausea (36.0%), rash (28.1%), headache (25.9%), cough (25.2%), diarrhea (22.3%)

Huang 2015

Skin rash (39.5%), nausea (5.26%), diarrhea (7.89%)

NA

King 2014

Nausea (36.0%), rash (28.1%), headache (25.9%), cough (25.2%), diarrhea (22.3%)

Acute exacerbation of IPF, elevated liver enzymes, pneumonia (both 1.1%)

Lei 2018

Photosensitivity, loss of appetite, fatigue

NA

Li 2015

NA

NA

Li 2016

Gastrointestinal reaction, abnormal liver function

NA

Taniguchi 2010

Photosensitivity (51.4%), nasopharyngitis (49.5%), anorexia (16.5%)

Photosensitivity (2.8%), lung cancer (1.8%), fever (1.8%), respiratory failure (1.8%)